Liraglutide treatment improves the coronary microcirculation in insulin resistant Zucker obese rats on a high salt diet.

In a rat model of metabolic syndrome, chronic LIRA treatment improved the capacity for NO-mediated dilation throughout the coronary macro and microcirculations and partially normalized myocardial remodeling independent of changes in body mass or blood glucose.